Skip to Content
Merck
  • Role of Aberrant Spontaneous Neurotransmission in SNAP25-Associated Encephalopathies.

Role of Aberrant Spontaneous Neurotransmission in SNAP25-Associated Encephalopathies.

Neuron (2020-11-05)
Baris Alten, Qiangjun Zhou, Ok-Ho Shin, Luis Esquivies, Pei-Yi Lin, K Ian White, Rong Sun, Wendy K Chung, Lisa M Monteggia, Axel T Brunger, Ege T Kavalali
ABSTRACT

SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) complex, composed of synaptobrevin, syntaxin, and SNAP25, forms the essential fusion machinery for neurotransmitter release. Recent studies have reported several mutations in the gene encoding SNAP25 as a causative factor for developmental and epileptic encephalopathies of infancy and childhood with diverse clinical manifestations. However, it remains unclear how SNAP25 mutations give rise to these disorders. Here, we show that although structurally clustered mutations in SNAP25 give rise to related synaptic transmission phenotypes, specific alterations in spontaneous neurotransmitter release are a key factor to account for disease heterogeneity. Importantly, we identified a single mutation that augments spontaneous release without altering evoked release, suggesting that aberrant spontaneous release is sufficient to cause disease in humans.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Deoxyribonuclease I from bovine pancreas, Type IV, lyophilized powder, ≥2,000 Kunitz units/mg protein
Sigma-Aldrich
D(−)-2-Amino-5-phosphonopentanoic acid, NMDA receptor antagonist
Sigma-Aldrich
Lysozyme from chicken egg white, powder or granules, ≥39,000 units/mg protein
Sigma-Aldrich
Cytosine β-D-arabinofuranoside hydrochloride, crystalline
Sigma-Aldrich
CNQX, ≥98% (HPLC), solid
Sigma-Aldrich
CNQX disodium salt hydrate, ≥98% (HPLC), solid
Sigma-Aldrich
Picrotoxin, powder